Category: Company News

The proposed acquisition would expand Brenmiller’s first BrenX energy platform in Hungary, providing additional capacity for renewable energy, storage and future infrastructure projects. Key Investor Takeaways Why (NASDAQ:BNRG) Stock Is in Focus Brenmiller Energy announced a commercial term sheet to purchase approximately 10,872 square meters of industrial land adjacent to its recently acquired operating solar…

The latest contract renewals expand Circle8’s recurring revenue base and add to a series of major public sector agreements announced during 2026. Key Investor Takeaways Why (NASDAQ:CIRC) Stock Is in Focus Circle8 announced contract extensions with two long-standing public sector customers in the Netherlands, adding approximately US$20 million in annual contract value to its existing…

Braiin introduced ARIA, an AI-native platform built to automate multi-step real estate workflows, as the company expands its presence in the growing real estate software and agentic AI markets. Key Investor Takeaways Why (NASDAQ:BRAI) Stock Is in Focus Braiin has unveiled ARIA, its new agentic AI workforce designed to automate operational processes across the real…

Independent third-party testing expands the performance case for NEXBOARD, adding new data on durability, fire safety, moisture resistance, and sustainability that could influence future commercial adoption. Key Investor Takeaways Why (USOTC:XERI) Stock Is in Focus Xeriant announced new independent laboratory results for its NEXBOARD eco-composite construction panel, providing additional validation of the product’s mechanical, physical…

The software update expands Lucyd smart glasses with Claude AI while introducing a multi-model platform that also supports ChatGPT. Key Investor Takeaways Why LUCY Stock Is in Focus Innovative Eyewear announced that it has developed a Claude AI integration for its Lucyd smart eyewear platform, with the software rollout scheduled to begin next week across…

The planned analytical study is designed to strengthen manufacturing characterization of EL-22 as development of the company’s engineered probiotic therapy continues. Key Investor Takeaways Why ELAB Stock Is in Focus NorthStrive Biosciences announced plans to initiate an independent flow cytometry, or FACS, analysis program for EL-22, its engineered Lactobacillus casei-based therapeutic candidate. According to the…

The acquisition gives T3 Defense a majority stake in an Israeli drone and counter-UAV developer, adding field-tested technologies and expanding its presence in a growing defense market. Key Investor Takeaways Why DFNS Stock Is in Focus T3 Defense announced the acquisition of a 60% interest in Project35, an Israeli developer and manufacturer of drones, aerial…

The proposed agreement is designed to accelerate commercialization of the company’s AI imaging platform while targeting an estimated $1 million profit during the initial cooperation phase. Key Investor Takeaways Why JZXN Stock Is in Focus Jiuzi Holdings announced that it intends to enter into a cooperation agreement with a company specializing in AI intelligent imaging…

The company outlined a new business strategy combining peptide research, AI-enabled discovery, and a planned U.S. telehealth services platform focused on peptide-based therapies. Key Investor Takeaways Why FITY Stock Is in Focus Fifty 1 Labs announced a strategic evolution into peptide biotechnology and telehealth, outlining a platform built around peptide research, AI-assisted discovery and future…

The proposed $400 million Canadian project could become the company’s first international development while expanding its pipeline of large-scale mixed-use opportunities. Key Investor Takeaways Why SNTX Stock Is in Focus Suntex Enterprises announced that it is in advanced discussions regarding a proposed collaboration on a mixed-use development project in Canada with an estimated development value…